Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem ...

Cidara Therapeutics, Inc.’s CDTX share price has surged by 6.27%, which has investors questioning if this is right time to ...

Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Gosselies, Belgium Saturday, April 26, 2025, 16:00 Hrs [IST] ...

Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.

Lineage Cell Therapeutics, Inc.’s LCTX share price has dipped by 5.08%, which has investors questioning if this is right time ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be available following the event on the Candel website at Candel Media. * Dr.

Candel's clinical development program for CAN-2409 includes completed positive phase 2a clinical trials in both non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), as ...